These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3449516)

  • 1. Four years of Bangladesh National Drug Policy.
    Islam N
    J Assoc Physicians India; 1987 Nov; 35(11):777-9. PubMed ID: 3449516
    [No Abstract]   [Full Text] [Related]  

  • 2. The menace of substandard drugs.
    Roy J
    World Health Forum; 1994; 15(4):406-7. PubMed ID: 7999239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National drug policy of Bangladesh: some pitfalls in implementation.
    Chowdhury FR; Ahasan HA; Rahman MM
    J Coll Physicians Surg Pak; 2006 May; 16(5):368-70. PubMed ID: 16756785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug policy in Bangladesh.
    Hasan M; Islam N
    Trop Gastroenterol; 1987; 8(1):3-8. PubMed ID: 3603683
    [No Abstract]   [Full Text] [Related]  

  • 5. Essential drugs in the Gambia.
    Jallow MT
    World Health Forum; 1993; 14(2):136-9. PubMed ID: 8185753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of drug use survey in Bangladesh.
    Essent Drugs Monit; 1993; (16):20. PubMed ID: 12319052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Children and bankers in Bangladesh].
    Hartmann B
    Temas Poblac; 1991 Jun; 1(2):51-5. PubMed ID: 12284143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 9. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 10. Bangladesh: National Population Policy approved.
    Asian Popul Programme News; 1977; 6(1):16. PubMed ID: 12260243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EURO-Medicines: a European program for bringing into agreement public health policies on drugs].
    Calamo-Specchia F; Bucci R; Folino-Gallo P
    Ann Ig; 1998; 10(5-6):405-12. PubMed ID: 10052204
    [No Abstract]   [Full Text] [Related]  

  • 13. Priorities for pharmaceutical policies in developing countries: results of a Delphi survey.
    Rainhorn JD; Brudon-Jakobowicz P; Reich MR
    Bull World Health Organ; 1994; 72(2):257-64. PubMed ID: 8205646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug supply strategies, constraints and prospects in Nigeria.
    Yusuff KB; Tayo F
    Afr J Med Med Sci; 2004 Dec; 33(4):389-94. PubMed ID: 15977451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bangladesh pharmaceutical policy and politics.
    Reich MR
    Health Policy Plan; 1994 Jun; 9(2):130-43. PubMed ID: 15726775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National drug policy reform for noncommunicable diseases in low-resource countries: an example from Bangladesh.
    Islam SMS; Islam MT; Islam A; Rodgers A; Chow CK; Naheed A
    Bull World Health Organ; 2017 May; 95(5):382-384. PubMed ID: 28479640
    [No Abstract]   [Full Text] [Related]  

  • 18. Strengthening national health programmes. Applied research and technical assistance.
    Glimpse; 2000 Mar; 22(1):5-8. PubMed ID: 12349775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential drugs programmes in Africa.
    Laing R
    Afr Health; 1991 Nov; 14(1):32-3. PubMed ID: 12343453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical policy of the Andean sub-region.
    Essent Drugs Monit; 1993; (16):13-5. PubMed ID: 12319050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.